Literature DB >> 17188776

A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer.

Zhigang Xie1, Huili Guan, Xuesi Chen, Changhai Lu, Li Chen, Xiuli Hu, Quan Shi, Xiabin Jing.   

Abstract

A novel amphiphilic polymer-paclitaxel conjugate P(LGG-paclitaxel)-PEG-P(LGG-paclitaxel) has been prepared. It was derived from its parent polymer P(LGG)-PEG-P(LGG), poly{(lactic acid)-co-[(glycolic acid)-alt-(l-glutamic acid)]}-block-poly(ethylene glycol)-block-poly{(lactic acid)-co-[(glycolic acid)-alt-(l-glutamic acid)]}, which was prepared by ring-opening copolymerization of l-lactide (LLA) with (3s)-benzoxylcarbonylethyl-morpholine-2,5-dione (BEMD) in the presence of dihydroxyl PEG with molecular weight of 4600 as a macroinitiator using stannous octoate (Sn(Oct)(2)) as catalyst, and by subsequent catalytic hydrogenation. It could self-assemble into micelles in an aqueous system with P(LGG-paclitaxel) block in the core and PEG in the shell. ESEM and DLS analysis of the micelles revealed a homogeneous spherical morphology and a unimodal size distribution. In vitro release of paclitaxel from the conjugate micelles showed that its release rate depended on pH value and was higher at lower pH than in neutral condition. In vitro antitumor activity of the paclitaxel conjugate against rat brain glioma C6 cells was evaluated by MTT method. The results showed that the paclitaxel can be released from the conjugate without losing cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188776     DOI: 10.1016/j.jconrel.2006.11.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel.

Authors:  Yixian Huang; Jianqin Lu; Xiang Gao; Jiang Li; Wenchen Zhao; Ming Sun; Donna Beer Stolz; Raman Venkataramanan; Lisa Cencia Rohan; Song Li
Journal:  Bioconjug Chem       Date:  2012-06-20       Impact factor: 4.774

2.  Novel biodegradable polylactide/poly(ethylene glycol) micelles prepared by direct dissolution method for controlled delivery of anticancer drugs.

Authors:  Liu Yang; Xiaohan Wu; Feng Liu; Yourong Duan; Suming Li
Journal:  Pharm Res       Date:  2009-08-08       Impact factor: 4.200

3.  Histological analysis of anti-cancer drug loaded, targeted Mn:ZnS quantum dots in metastatic lesions of 4T1 challenged mice.

Authors:  Ibrahim Birma Bwatanglang; Faruq Mohammad; Nor Azah Yusof; Nurul Elyani Mohammed; Nadiah Abu; Noorjahan Banu Alitheen; Jaafar Abdullah; Mohd Zubir Hussein; Yusuf Abba; Noraini Nordin; Nur Rizi Zamberi
Journal:  J Mater Sci Mater Med       Date:  2017-08-08       Impact factor: 3.896

4.  PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.

Authors:  Xiaolan Zhang; Jianqin Lu; Yixian Huang; Wenchen Zhao; Yichao Chen; Jiang Li; Xiang Gao; Raman Venkataramanan; Ming Sun; Donna Beer Stolz; Lin Zhang; Song Li
Journal:  Bioconjug Chem       Date:  2013-03-01       Impact factor: 4.774

5.  Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy.

Authors:  Hima Bindu Ruttala; Young Tag Ko
Journal:  Pharm Res       Date:  2014-09-12       Impact factor: 4.200

6.  Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.

Authors:  Rui Zhang; Kui Luo; Jiyuan Yang; Monika Sima; Yongen Sun; Margit M Janát-Amsbury; Jindřich Kopeček
Journal:  J Control Release       Date:  2012-12-20       Impact factor: 9.776

Review 7.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

Review 8.  Self-assembling prodrugs.

Authors:  Andrew G Cheetham; Rami W Chakroun; Wang Ma; Honggang Cui
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

9.  In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.

Authors:  YanXin Yu; Shan Xu; Hong You; YinJie Zhang; Bo Yang; XiaoYang Sun; LingLin Yang; Yue Chen; ShaoZhi Fu; JingBo Wu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profile.

Authors:  Basavaraj Siddalingappa; Heather A E Benson; David H Brown; Kevin T Batty; Yan Chen
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.